Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury.

Lee CG, Kim JG, Kim HJ, Kwon HK, Cho IJ, Choi DW, Lee WH, Kim WD, Hwang SJ, Choi S, Kim SG.

Kidney Int. 2014 Nov;86(5):943-53. doi: 10.1038/ki.2014.117. Epub 2014 Apr 23.

PMID:
24759152
2.

Phlda3, a urine-detectable protein, causes p53 accumulation in renal tubular cells injured by cisplatin.

Lee CG, Kang YJ, Kim HS, Moon A, Kim SG.

Cell Biol Toxicol. 2015 Apr;31(2):121-30. doi: 10.1007/s10565-015-9299-4. Epub 2015 Mar 26.

PMID:
25809501
3.

miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle.

Hudson MB, Rahnert JA, Zheng B, Woodworth-Hobbs ME, Franch HA, Price SR.

Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C314-9. doi: 10.1152/ajpcell.00395.2013. Epub 2014 May 28.

4.

miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.

Adlakha YK, Saini N.

Cell Death Dis. 2013 Mar 14;4:e542. doi: 10.1038/cddis.2013.46.

5.
6.

MicroRNA-155 deficient mice experience heightened kidney toxicity when dosed with cisplatin.

Pellegrini KL, Han T, Bijol V, Saikumar J, Craciun FL, Chen WW, Fuscoe JC, Vaidya VS.

Toxicol Sci. 2014 Oct;141(2):484-92. doi: 10.1093/toxsci/kfu143. Epub 2014 Jul 11.

7.

MicroRNA-34a Suppresses Autophagy in Tubular Epithelial Cells in Acute Kidney Injury.

Liu XJ, Hong Q, Wang Z, Yu YY, Zou X, Xu LH.

Am J Nephrol. 2015;42(2):168-75. doi: 10.1159/000439185. Epub 2015 Sep 26.

PMID:
26406385
8.

MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival.

Bhatt K, Zhou L, Mi QS, Huang S, She JX, Dong Z.

Mol Med. 2010 Sep-Oct;16(9-10):409-16. doi: 10.2119/molmed.2010.00002. Epub 2010 Apr 9.

9.

MiR-107 induces TNF-α secretion in endothelial cells causing tubular cell injury in patients with septic acute kidney injury.

Wang S, Zhang Z, Wang J, Miao H.

Biochem Biophys Res Commun. 2017 Jan 29;483(1):45-51. doi: 10.1016/j.bbrc.2017.01.013. Epub 2017 Jan 4.

PMID:
28063928
10.

miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.

Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM.

J Hepatol. 2013 Jan;58(1):119-25. doi: 10.1016/j.jhep.2012.08.008. Epub 2012 Aug 15.

PMID:
22902550
11.

Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.

Kim HJ, Joe Y, Yu JK, Chen Y, Jeong SO, Mani N, Cho GJ, Pae HO, Ryter SW, Chung HT.

Biochim Biophys Acta. 2015 Jul;1852(7):1550-9. doi: 10.1016/j.bbadis.2015.04.017. Epub 2015 Apr 23.

12.

A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.

Lee J, Padhye A, Sharma A, Song G, Miao J, Mo YY, Wang L, Kemper JK.

J Biol Chem. 2010 Apr 23;285(17):12604-11. doi: 10.1074/jbc.M109.094524. Epub 2010 Feb 25.

13.

SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53.

Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W.

Am J Physiol Renal Physiol. 2011 Aug;301(2):F427-35. doi: 10.1152/ajprenal.00258.2010. Epub 2011 May 18.

14.

Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.

Kurinna S, Stratton SA, Tsai WW, Akdemir KC, Gu W, Singh P, Goode T, Darlington GJ, Barton MC.

Hepatology. 2010 Sep;52(3):1023-32. doi: 10.1002/hep.23746.

15.

Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury.

Li Z, Deng X, Kang Z, Wang Y, Xia T, Ding N, Yin Y.

J Nephrol. 2016 Feb;29(1):27-36. doi: 10.1007/s40620-015-0217-x. Epub 2015 Jul 7.

PMID:
26149640
16.

MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.

Luan S, Sun L, Huang F.

Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007.

PMID:
20470934
17.

5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.

Hu Z, Fan H, Lv G, Zhou Q, Yang B, Zheng J, Cao W.

J Dermatol Sci. 2015 Aug;79(2):155-62. doi: 10.1016/j.jdermsci.2015.04.010. Epub 2015 May 1.

PMID:
25982144
18.

SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.

Herbert KJ, Cook AL, Snow ET.

Toxicol Appl Pharmacol. 2014 Jun 15;277(3):288-97. doi: 10.1016/j.taap.2014.04.001. Epub 2014 Apr 12.

PMID:
24726431
19.

c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.

Ferreira DM, Afonso MB, Rodrigues PM, Simão AL, Pereira DM, Borralho PM, Rodrigues CM, Castro RE.

Mol Cell Biol. 2014 Mar;34(6):1100-20. doi: 10.1128/MCB.00420-13. Epub 2014 Jan 13.

20.

Protective effects of icariin-mediated SIRT1/FOXO3 signaling pathway on intestinal ischemia/reperfusion-induced acute lung injury.

Zhang F, Li ZL, Xu XM, Hu Y, Yao JH, Xu W, Jing HR, Wang S, Ning SL, Tian XF.

Mol Med Rep. 2015 Jan;11(1):269-76. doi: 10.3892/mmr.2014.2679. Epub 2014 Oct 16.

PMID:
25323330

Supplemental Content

Support Center